menu
    • menu

    Company profile for Gnosis by Lesaffre

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Gnosis by Lesaffre, we harness the power of microorganisms to transform compounds into usable nutritional actives, probiotics, and nutritional yeasts that benefit human wellbeing. Our process is natural, is sustainable, and will shape the future of the industry. Our process is called biotransformation. We strive to create a world that moves better, digests better, ages better, feels better, and, ultimately, lives better tha...
    At Gnosis by Lesaffre, we harness the power of microorganisms to transform compounds into usable nutritional actives, probiotics, and nutritional yeasts that benefit human wellbeing. Our process is natural, is sustainable, and will shape the future of the industry. Our process is called biotransformation. We strive to create a world that moves better, digests better, ages better, feels better, and, ultimately, lives better thanks to microorganisms and biotransformation

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gnosis by LesaffreFrance Flag
    Country
    Country
    France
    Address
    Address
    137 rue Gabriel Péri 59700 Marcq-en-Baroeul France
    Telephone
    Telephone
    +33 (0)3 20 81 61 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://gnosisbylesaffre.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gnosis-by-lesaffre/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/gnosislesaffre

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SunWay Biotech and Gnosis Launch MenaQ7® Metabolic Featuring ANKASCIN® 568-R Ingredient

    Details:

    The partnership aims to launch SunWay's inaugural product, MenaQ7® Metabolic, featuring two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R.


    Lead Product(s): Menaquinone-7,Ankascin 568-R

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Vitamins/Minerals/Inorganic Salts

    Recipient: SunWay Biotech

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership March 14, 2024

    blank

    01

    Gnosis by Lesaffre

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Gnosis by Lesaffre

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Menaquinone-7,Ankascin 568-R

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved FDF

    Recipient : SunWay Biotech

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    SunWay Biotech and Gnosis Launch MenaQ7® Metabolic Featuring ANKASCIN® 568-R Ingredient

    Details : The partnership aims to launch SunWay's inaugural product, MenaQ7® Metabolic, featuring two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R.

    Product Name : Undisclosed

    Product Type : Vitamins/Minerals/Inorganic Salts

    Upfront Cash : Undisclosed

    March 14, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma

    Details:

    This acquisition brings together globally recognized vitamin K2 brands vitaMK7® and MenaQ7® and allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.


    Lead Product(s): Menaquinone-7

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Vitamins/Minerals/Inorganic Salts

    Recipient: NattoPharma

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition May 25, 2021

    blank

    02

    Gnosis by Lesaffre

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Gnosis by Lesaffre

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Menaquinone-7

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Approved FDF

    Recipient : NattoPharma

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma

    Details : This acquisition brings together globally recognized vitamin K2 brands vitaMK7® and MenaQ7® and allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.

    Product Name : Undisclosed

    Product Type : Vitamins/Minerals/Inorganic Salts

    Upfront Cash : Undisclosed

    May 25, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Efficacy of Non-animal Chondroitin Sulphate for Overweight Subjects With Knee Ostoarthritis.

    Details:

    Chondroitin Sulfate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Osteoarthritis, Knee.


    Lead Product(s): Chondroitin Sulfate Sodium

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Miscellaneous

    Recipient: Azienda di Servizi alla Persona di Pavia

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 06, 2018

    blank

    03

    Gnosis by Lesaffre

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Gnosis by Lesaffre

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Chondroitin Sulfate Sodium

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Phase IV

    Recipient : Azienda di Servizi alla Persona di Pavia

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Efficacy of Non-animal Chondroitin Sulphate for Overweight Subjects With Knee Ostoarthritis.

    Details : Chondroitin Sulfate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Osteoarthritis, Knee.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    November 06, 2018

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Gnosis by Lesaffre and get a quotation

    Gnosis by Lesaffre is a supplier offers 10 products (APIs, Excipients or Intermediates).

    Find a price of Teicoplanin bulk offered by Gnosis by Lesaffre

    Find a price of Ademetionine bulk offered by Gnosis by Lesaffre

    Find a price of Ademetionine 1,4-Butanedisulfonate bulk offered by Gnosis by Lesaffre

    Find a price of Ademetionine Disulfate Tosylate bulk offered by Gnosis by Lesaffre

    Find a price of Choline bulk offered by Gnosis by Lesaffre

    Find a price of Chondroitin Sulfate Sodium bulk offered by Gnosis by Lesaffre

    Find a price of Dalbavancin bulk offered by Gnosis by Lesaffre

    Find a price of Folic Acid bulk offered by Gnosis by Lesaffre

    Find a price of Silymarin bulk offered by Gnosis by Lesaffre

    Find a price of Vitamin K2 bulk offered by Gnosis by Lesaffre

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search